Julia Moore Vogel, PhD

Assistant Professor & Sr. Program Director

Department of Translational Medicine

Research Focus

Our group addresses complex illnesses by conducting participant-centric health research and clinical trials to learn about and address these conditions. We focus on decentralized studies that use digital technologies, sensors, and at-home biospecimen collection to accommodate individuals across the country and around the world.

Education

Contact

Joint Appointments

Research Interests

In the Media

Weight-loss drug Zepbound is being tested as a treatment for long COVID

WIRED

Translational Medicine Long COVID Translational Institute

In the Media

Remote Long COVID trial to evaluate repurposed drug across US

ContagionLive

Translational Medicine Long COVID Translational Institute

In the Media

A Q&A with Julia Vogel, a researcher fighting long COVID and searching for relief

The San Diego Union-Tribune

Translational Medicine Long COVID Respiratory Disease Translational Institute

In the Media

5 years later, long Covid is still a medical mystery: What scientists have learned

NBC News

Translational Medicine COVID-19 Translational Institute

In the Media

Can Paxlovid relieve Long COVID symptoms? For some, yes

Science Friday

Translational Medicine Long COVID Translational Institute

Podcast

The long haul: Personal and scientific insights into long COVID with Julia Moore Vogel

Long COVID affects millions of people worldwide, yet many questions about the condition remain unanswered. In this episode of Science Changing Life, Julia Moore Vogel, PhD, shares what it’s like to study—and live with—long COVID. As the senior director of the All of Us Research Program, Julia discusses how her experience has fueled innovative research to improve symptom management and health equity for patients with the condition. Listen in to learn how Julia transforms personal challenges into professional breakthroughs.

Translational Institute Long COVID

In the Media

Study aims to help people with long COVID to ‘pace themselves’

KPBS

Translational Medicine Digital Medicine Long COVID Translational Institute

News

Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief

Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.

Translational Medicine Translational Institute